Independent Insights, a Health Mart Podcast

Health Mart

Independent Insights, a Health Mart Podcast brings together independent pharmacy owners and other community pharmacy experts to inspire all pharmacy team members to not just survive, but thrive in building practices that cater to the needs of local communities. Plug in to hear ways to innovate patient care services and strengthen the overall health of your pharmacy business.    Plus, sharpen your clinical skills with GameChangers Clinical Conversations - a weekly pharmacotherapy podcast featuring the latest game-changing advances in patient care. New episodes arrive every Monday and are available for CE credit. Check the show notes for instructions on how to redeem your credit.   Happy listening!

  1. Alpha-Gal Syndrome and the Role of the Pharmacist

    6D AGO

    Alpha-Gal Syndrome and the Role of the Pharmacist

    Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case trends—while highlighting how pharmacists can play a critical role in helping patients navigate safe OTC and prescription therapies by screening for allergenic excipients. You will gain practical knowledge to support patient education, ensure safe medication use, and guide appropriate referrals. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Geoff Wall, PharmD, BCPS Professor of Pharmacy Practice Drake University   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll! CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the pathophysiology, triggers, and clinical presentation of alpha‑gal syndrome. 2. Identify pharmacist‑led strategies for patient counseling, medication review, and referral when AGS is suspected or confirmed. Rachel Maynard and Geoff Wall have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-058-H01-P Initial release date: 3/30/2026 Expiration date: 3/30/2027 Additional CPE details can be found here.

    33 min
  2. MAR 25

    Episode 23: Community Roots to Clinical Impact: Inside a Pharmacy of the Year Winner

    What does it look like to build a pharmacy that not only survives—but thrives? In this episode of Independent Insights, host Britney Woods talks with Dave Randolph, owner of Dave’s Pharmacy, and Mikayla Smith, pharmacy manager, about their journey as an independent pharmacy serving rural communities. Together, these Health Mart Pharmacy of the Year award winners discuss expanding clinical services, supporting staff through growth, and finding sustainable ways to meet patient needs when access to care is limited. Through candid stories and practical lessons, this episode highlights how thoughtful advocacy, innovation, and leadership can help strengthen both patient care and the longterm health of an independent pharmacy.  Host Britney Woods, PharmD Sr. Manager, Community Pharmacy McKesson / Health Mart Guests Dave Randolph, RPh Pharmacy Owner Dave's Pharmacy Mikayla Smith, CPhT AA Business Pharmacy Manager Dave's Pharmacy References Tune into these additional Independent Insights episodes for more details on ECAPs and hosting a legislator mentioned during this podcast episode: Episode 19: Your Pharmacy, Your Voice: Why HR3164 (ECAPS) Needs YouEpisode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

    49 min
  3. How AI is Reshaping Patient Care

    MAR 23

    How AI is Reshaping Patient Care

    Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and tools that support patient care and clinical decision-making. You will gain insight into practical considerations, limitations, and ethical responsibilities pharmacists must navigate as AI becomes more integrated into practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Timothy Aungst, PharmD Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health Sciences   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll! CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current and potential uses of AI that support pharmacist-led patient care services. 2. Describe considerations, limitations, and ethical concerns related to implementing AI tools in pharmacy practice. Rachel Maynard and Timothy Aungst have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-060-H04-P Initial release date: 3/23/2026 Expiration date: 3/23/2027 Additional CPE details can be found here.

    35 min
  4. Second-Generation Antipsychotics as Adjunctive Therapy for Depression

    MAR 16

    Second-Generation Antipsychotics as Adjunctive Therapy for Depression

    Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical rationale for their use, highlights newly approved options, and examines key safety, efficacy, and monitoring considerations. You will gain practical guidance to support patient selection, counseling, and shared decision-making when these agents are incorporated into depression management. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Sarah Grady, PharmD, BCPS, BCPP Professor of Pharmacy Practice, Clinical Pharmacist Drake University/Broadlawns Medical Center Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only. To learn more about Health Mart, click here: https://join.healthmart.com/ PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll! CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of second-generation (atypical) antipsychotics as adjunctive therapy in the management of major depressive disorder. 2. Identify pharmacist-relevant considerations for counseling, monitoring, and risk benefit assessment when second-generation antipsychotics are used for depression. Rachel Maynard and Sarah Grady have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-059-H01-P Initial release date: 3/16/2026 Expiration date: 3/16/2027 Additional CPE details can be found here.

    34 min
  5. Recent Updates on GLP-1 Therapies

    MAR 9

    Recent Updates on GLP-1 Therapies

    GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP Professor, Pharmacy Practice and Clinical Pharmacist Midwestern University   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll! CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations. 2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment. Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.  Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated. 0.1 CEU/1.0 Hr UAN: 0107-0000-26-081-H01-P Initial release date: 3/9/2026 Expiration date: 3/9/2027 Additional CPE details can be found here.

    46 min
  6. Shared Clinical Decision-Making and the Pharmacist’s Role

    MAR 2

    Shared Clinical Decision-Making and the Pharmacist’s Role

    Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course explains what shared clinical decision‑making means in the context of immunizations, examines how it affects pediatric vaccine discussions, and highlights opportunities for pharmacists to support informed, individualized conversations with patients and caregivers. You will gain clarity on how to apply shared clinical decision‑making principles—alongside proven health coaching strategies—to strengthen patient trust and foster more meaningful dialogue in pharmacy practice. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Elizabeth Skoy, PharmD, RPh Professor North Dakota State University   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll! CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe shared clinical decision-making and how it applies to recent pediatric vaccine recommendations. 2. Identify the pharmacist's roles in counseling, education, and facilitating shared clinical decision-making conversations with patients and caregivers.  Rachel Maynard and Elizabeth Skoy have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-077-H01-P Initial release date: 3/2/2026 Expiration date: 3/2/2027 Additional CPE details can be found here.

    43 min
  7. Balancing the Benefits and Risks of Gabapentin

    FEB 23

    Balancing the Benefits and Risks of Gabapentin

    As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety concerns, and examines pharmacist-led opportunities to reduce risks through education and medication review. You will walk away with timely insights to help navigate the growing complexities and responsibilities associated with gabapentin use. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Nakia Duncan, PharmD BCGP, BCPS Associate Professor/ Pain& Palliative Care Clinical Pharmacist Texas Tech Health Science Center - School of Pharmacy   Pharmacists, REDEEM YOUR CPE HERE! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ CPE INFORMATION  Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize recent national prescribing trends and safety concerns associated with gabapentin use. 2. Identify pharmacist-led strategies to support safe use, patient education, and medication review involving gabapentin. Rachel Maynard and Nakia Duncan have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-053-H01-P Initial release date: 2/23/2026 Expiration date: 2/23/2027 Additional CPE details can be found here.

    30 min
5
out of 5
11 Ratings

About

Independent Insights, a Health Mart Podcast brings together independent pharmacy owners and other community pharmacy experts to inspire all pharmacy team members to not just survive, but thrive in building practices that cater to the needs of local communities. Plug in to hear ways to innovate patient care services and strengthen the overall health of your pharmacy business.    Plus, sharpen your clinical skills with GameChangers Clinical Conversations - a weekly pharmacotherapy podcast featuring the latest game-changing advances in patient care. New episodes arrive every Monday and are available for CE credit. Check the show notes for instructions on how to redeem your credit.   Happy listening!

You Might Also Like